Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 28.95B | 25.36B | 30.25B | 29.96B | 22.52B |
Gross Profit | 10.14B | 1.64B | 8.59B | 10.05B | 7.63B |
EBITDA | 3.62B | 2.50B | 4.22B | 6.19B | 4.21B |
Net Income | 1.33B | 621.90M | 2.44B | 3.97B | 2.37B |
Balance Sheet | |||||
Total Assets | 41.25B | 35.28B | 31.28B | 27.60B | 21.25B |
Cash, Cash Equivalents and Short-Term Investments | 4.35B | 4.11B | 4.46B | 4.95B | 3.14B |
Total Debt | 14.38B | 10.48B | 9.32B | 8.18B | 7.60B |
Total Liabilities | 26.58B | 21.80B | 18.30B | 15.69B | 12.71B |
Stockholders Equity | 14.66B | 13.48B | 12.98B | 11.91B | 8.54B |
Cash Flow | |||||
Free Cash Flow | -3.36B | -522.90M | 847.60M | 1.98B | 2.61B |
Operating Cash Flow | 1.66B | 2.45B | 4.65B | 4.81B | 3.35B |
Investing Cash Flow | -4.20B | -2.35B | -3.25B | -4.47B | -1.05B |
Financing Cash Flow | 2.47B | -185.20M | -1.53B | -516.60M | -1.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ₹26.80B | 40.35 | 0.37% | 16.31% | 3.08% | ||
65 Neutral | ₹30.90B | 23.12 | 0.88% | 13.56% | 22.14% | ||
63 Neutral | ₹16.09B | 21.60 | 0.96% | -0.87% | -82.44% | ||
62 Neutral | ₹7.37B | 12.87 | 0.33% | 13.64% | 252.97% | ||
58 Neutral | ₹28.34B | 19.21 | 0.37% | 14.74% | 84.64% | ||
58 Neutral | ₹42.70B | 30.00 | 0.51% | 11.07% | ― | ||
54 Neutral | C$45.05M | 57.91 | 15.08% | 4.51% | 1.39% | -26.37% |